Patient engagement in health technology assessment (HTA) and the regulatory process: what about rheumatology?

RMD Open. 2020 Nov;6(3):e001286. doi: 10.1136/rmdopen-2020-001286.

Maarten de Wit¹, Francis Guillemin^{2

3}, Sabine Grimm⁴, Annelies Boonen⁵, Bruno Fautrel^{6

7}, Manuela Joore⁴

¹ Patient Research Partner, EULAR, Zaltbommel, Netherlands martinusdewit@hotmail.com.
² School of Public Health, Nancy, France.
³ Universite de Lorraine, APEMAC, School of Public Health, Nancy, France.
⁴ Maastricht University Medical Centre+, Maastricht, Netherlands.
⁵ Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, and the Caphri Research Institute Maastricht University, Maastricht, Netherlands.
⁶ Rheumatology, Assistance Publique - Hopitaux De Paris, Paris, France.
⁷ GRC08 - Iplesp, UPMC Faculte De Medecine, Paris, France.

No abstract available

Keywords: Economics; Epidemiology; Health services research.

MeSH terms